Search for: "Hill v. Pfizer, Inc.,"
Results 1 - 20
of 32
Sorted by Relevance
|
Sort by Date
25 Oct 2014, 9:01 pm
., Inc. v. [read post]
31 Jul 2017, 7:00 am
See generally Opposition Brief of Defendants-Appellees Pfizer Inc., Pfizer International LLC, and Greenstone LLC [cited as Pfizer]. [read post]
14 Aug 2013, 1:57 pm
Pfizer, Inc., 2012 WL 2971550, at *6 (D. [read post]
30 Jan 2015, 8:19 pm
When the Supreme Court delivered its decision in Matrixx Initiatives, Inc. v. [read post]
31 Jan 2014, 2:00 pm
Pfizer, Inc., 720 F.3d 739, 747 (8th Cir. 2013) (same). [read post]
20 Mar 2009, 2:05 am
Pfizer Hospital Products Group, Inc., 783 F.Supp. 1466, 1475 (D. [read post]
6 Jan 2014, 11:21 am
Pfizer, Inc., 2013 U.S. [read post]
5 Jul 2007, 10:37 am
Sterling Drug, Inc., 416 S.W.2d 143, 146-47 (Mo. 1967).Montana: Hill v. [read post]
2 Oct 2008, 12:36 pm
Danek Medical, Inc., 1999 WL 1054864, *6 (M.D. [read post]
29 Apr 2011, 7:43 am
Pfizer Inc. [read post]
10 Jun 2009, 10:00 pm
Pfizer, Inc., 584 F. [read post]
6 Jul 2007, 4:29 am
Pfizer, Inc., 153 S.W.3d 758, 761 (Ky. 2004); McCombs v. [read post]
3 Nov 2010, 1:21 am
Pharmachemie (EPLAW) US: Supreme Court to hear Bayh-Dole patent ownership dispute: Stanford v Roche (Patently-O) (IPKat) (IPBiz) US: DoJ amicus brief in Myriad says no to patentability of genomic DNA: AMP v USPTO (IPBiz) (Inventive Step) (Patently-O) (Patent Docs) (Holman’s Biotech IP Blog) US: Briefing update: AMP v USPTO (Patent Docs) US: BIO and AUTM file amicus brief in Myriad case (PatentlyBIOtech) US: Myriad files appeal brief in AMP v USPTO (Patent… [read post]
13 Sep 2007, 10:48 am
But this time Bexis has gotten special dispensation (stop heading for the hills, it's not that bad). [read post]
2 Jun 2011, 12:46 pm
Pfizer, Inc., 153 S.W.3d 758, 761 (Ky. 2004) (dictum also extends rule to medical devices). [read post]
19 Apr 2013, 5:35 pm
Lowe’s Home Centers, Inc., 563 F. 3d 171, 178 (6th Cir 2009); Westberry v. [read post]
16 Jun 2015, 7:22 am
Alcon Labs., Inc., 201 F. [read post]
3 Feb 2011, 2:11 pm
Pfizer, Inc., 851 F. [read post]
23 Jan 2020, 10:37 pm
Ahmed-Saucedo’s dismissal of the importance of a dose-response relationship, another Hill factor, as unimportant sealed her fate. [read post]
4 Sep 2013, 4:30 am
Pfizer, Inc., 2013 U.S. [read post]
